Genome & Company (KOSDAQ:314130)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,575.00
+15.00 (0.59%)
Last updated: Aug 29, 2025, 9:07 AM KST

Genome & Company Market Cap

Genome & Company has a market cap or net worth of 79.58 billion as of August 28, 2025. Its market cap has decreased by -47.68% in one year.

Market Cap
79.58B
Enterprise Value
73.64B
Revenue
24.02B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,575.00

Market Cap Chart

Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 79.58B, an increase of 10.71%. That is a compound annual growth rate of 1.54%.

History

DateMarket Cap% Change
Aug 27, 202581.75B-4.05%
Dec 30, 202485.21B-51.64%
Dec 28, 2023176.21B-28.34%
Dec 29, 2022245.90B-47.55%
Dec 30, 2021468.83B-55.28%
Dec 30, 20201,048.46B224.28%
Dec 30, 2019 Pro Pro
Dec 28, 2018 Pro Pro
Dec 26, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition